Long COVID
Commentary
Clinical trials: Top priority for long COVID
Behavioral treatments including exercise, graded exercise therapy, and cognitive-behavioral therapy should not be trialed, let alone prioritized,...
Conference Coverage
Long-COVID rate may be higher with rheumatic diseases
The results highlight the need for close monitoring and optimized multidisciplinary care for long-term adverse events after COVID-19 in patients...
Feature
Researchers seek to understand post-COVID autoimmune disease risk
Three large studies link past SARS-CoV-2 infection to new-onset autoimmune disease, but it is not yet clear what drives this relationship.
From the Journals
Long-COVID patients respond differently to COVID vaccines
Differences could explain why some people experience symptoms for months while others recover faster.
Feature
Long COVID mobile monitoring study hunts for answers
Researchers plan to use mobile monitoring devices in the federally-funded RECOVER Initiative to provide doctors and patients with a wealth of...
From the Journals
Trial shows some relief for long COVID fatigue, researchers say
It was one of the first randomized double-blind placebo controlled trial for a possible treatment for long COVID.
Feature
Long COVID: ‘On par’ with heart disease, cancer, book says
“The clinical burden [of long COVID] is somewhere on par with the whole of heart disease all over again, or the whole of oncology all over again,...
Latest News
Long COVID hitting some states, minorities, women harder
The survey found that women, smokers, and those who had severe COVID-19 infections are most likely to have the disorder.
Feature
Doctor’s checklist for treating long COVID patients
Emerging research has identified a checklist of sorts that doctors should consider when a patient seeks care for what appears to be long COVID.
Commentary
COVID can mimic prostate cancer symptoms
“I had none of those previously reported experiences that could suddenly trigger a spike in PSA.”
Feature
‘Breakthrough’ study: Diabetes drug helps prevent long COVID
Metformin led to a 42% drop in long COVID among people who had a mild to moderate COVID-19 infection.